• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S NOVOPEN 6; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S NOVOPEN 6; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problem Inaccurate Delivery (2339)
Patient Problem Diabetic Ketoacidosis (2364)
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas).Diabetic ketoacidosis (dka) [diabetic ketoacidosis].Had not taken or had not taken correctly his insulin [incorrect dose administered by device].Case description: this serious spontaneous case from the united kingdom was reported by a nurse as "diabetic ketoacidosis (dka)(diabetic ketoacidosis)" with an unspecified onset date, "had not taken or had not taken correctly his insulin(incorrect dose administered by device)" with an unspecified onset date, and concerned a male patient who was treated with novopen 6 (insulin delivery device) from unknown start date for "device therapy", tresiba penfill (insulin degludec) (dose, frequency & route used-unk) from unknown start date for "drug used for unknown indication".Patient height, weight and bmi(body mass index) were not reported.Current condition: diabetes(type and duration not reported).Historical drug: tresiba u100 flex-touch.On an unknown date, prescription changed by a clinical pharmacist from tresiba u100 flex-touch pen to tresiba u100 penfil and novopen 6.Reporter informed that they do not know if the patient had full and proper training as to how to use the pen and cartridge correctly.On an unknown date, the patient experienced diabetic ketoacidosis as the patient had not taken or had not taken correctly his insulin.Batch number of novopen 6 and tresiba penfill were not reported.Action taken to novopen 6 was not reported.Action taken to tresiba penfill was reported as product discontinued.The outcome for the event "diabetic ketoacidosis (dka)(diabetic ketoacidosis)" was unknown.The outcome for the event "had not taken or had not taken correctly his insulin(incorrect dose administered by device)" was unknown.No further information available."this report is for a foreign device that is assessed as "similar" to us marketed novopen echo".
 
Event Description
Case description: investigation result: novopen® 6 - batch unknown.No investigation was possible, because neither sample nor batch number was available.Tresiba® penfill® (u100) - batch unknown.No investigation was possible, because neither sample nor batch number was available.Since last submission, this case has been updated with the following- investigation result updated.Imdrf annex b, c, d, and g codes updated.Narrative updated accordingly.Final manufacturer's comment: 06-dec-2023: the suspected device novopen 6 has not been returned to novo nordisk for evaluation.Batch number of the device unavailable despite repeated efforts to find the same.No batch trend analysis or reference sample analysis performed.No other confounding factors identified.With the available limited information regarding the handling of the suspected device, it is not possible to identify a clear root cause in relation to functionality of novopen 6.H3 continued: evaluation summary: novopen® 6 - batch unknown.No investigation was possible, because neither sample nor batch number was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 6
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S
bagsvaerd,,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S
krogshoejvej 55
bagsvaerd,, 2880
DA   2880
Manufacturer Contact
p.o. box 846
plainsboro, NJ 08536
8007276500
MDR Report Key18065963
MDR Text Key327292943
Report Number9681821-2023-00149
Device Sequence Number1
Product Code FMF
Combination Product (y/n)Y
Reporter Country CodeUK
PMA/PMN Number
K123766
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient SexMale
-
-